John Maxwell Net Worth

John Maxwell biography

John T. Maxwell CPA serves as Senior Vice President, Chief Financial Officer of the Company. Mr. Maxwell has served as our Senior Vice President - Chief Financial Officer since January 2017. Prior to joining our team, Mr. Maxwell held senior financial roles at WIL Research, InfoNXX, PanAmSat, ADP and General Signal, including, most recently, as Chief Financial Officer of WIL Research from September 2008 to April 2016. In addition, Mr. Maxwell served as a consultant from April 2016 until January 2017. Mr. Maxwell started his career at Ernst & Young, serving in the Dallas, New York and Stamford offices. Mr. Maxwell helped lead the successful strategic sale transactions by the private equity sponsors of WIL Research in April 2016 to Charles River Labs and of PanAmSat in 2006 to Intelsat. Mr. Maxwell also helped lead the initial public offering of PanAmSat in 2005 and multiple public and private debt transactions for WIL Research, InfoNXX and PanAmSat. Mr. Maxwell is a licensed certified public accountant and holds a B.B.A in Accounting from Texas Tech University and an M.B.A in Finance and International Business from New York University Stern School of Business.

What is the salary of John Maxwell?

As the Senior Vice President and Chief Financial Officer of Aquestive Therapeutics Inc, the total compensation of John Maxwell at Aquestive Therapeutics Inc is $1,054,120. There are 3 executives at Aquestive Therapeutics Inc getting paid more, with A. Mark Schobel having the highest compensation of $7,575,660.